IRIS
FABRAZZO, Michele
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 7.268
NA - Nord America 4.383
AS - Asia 3.062
SA - Sud America 564
AF - Africa 31
Continente sconosciuto - Info sul continente non disponibili 4
OC - Oceania 3
Totale 15.315
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.346
RU - Federazione Russa 2.318
IT - Italia 1.565
SG - Singapore 1.274
IE - Irlanda 1.095
CN - Cina 659
UA - Ucraina 590
HK - Hong Kong 552
BR - Brasile 502
GB - Regno Unito 458
DE - Germania 283
FR - Francia 279
SE - Svezia 278
FI - Finlandia 150
VN - Vietnam 123
TR - Turchia 120
GR - Grecia 98
JP - Giappone 89
IN - India 76
KR - Corea 75
NL - Olanda 36
PL - Polonia 30
BE - Belgio 21
AR - Argentina 20
BD - Bangladesh 18
CA - Canada 18
CH - Svizzera 14
AT - Austria 13
IQ - Iraq 12
ZA - Sudafrica 11
CO - Colombia 10
ES - Italia 10
EC - Ecuador 9
ID - Indonesia 9
MX - Messico 8
PY - Paraguay 8
VE - Venezuela 8
AE - Emirati Arabi Uniti 7
IR - Iran 7
MA - Marocco 6
UZ - Uzbekistan 6
CZ - Repubblica Ceca 5
LB - Libano 5
MY - Malesia 5
PK - Pakistan 5
TT - Trinidad e Tobago 5
EG - Egitto 4
EU - Europa 4
PT - Portogallo 4
CL - Cile 3
HU - Ungheria 3
KE - Kenya 3
LT - Lituania 3
RO - Romania 3
RS - Serbia 3
TN - Tunisia 3
AU - Australia 2
AZ - Azerbaigian 2
BH - Bahrain 2
DZ - Algeria 2
IL - Israele 2
JM - Giamaica 2
NO - Norvegia 2
NP - Nepal 2
OM - Oman 2
PE - Perù 2
SA - Arabia Saudita 2
SV - El Salvador 2
TW - Taiwan 2
AL - Albania 1
BA - Bosnia-Erzegovina 1
BN - Brunei Darussalam 1
BO - Bolivia 1
BW - Botswana 1
ET - Etiopia 1
IS - Islanda 1
JO - Giordania 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LV - Lettonia 1
MK - Macedonia 1
NI - Nicaragua 1
NZ - Nuova Zelanda 1
PA - Panama 1
PH - Filippine 1
PS - Palestinian Territory 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
UY - Uruguay 1
Totale 15.315
Salva come PNG Salva come JPEG
Città #
Dublin 1.077
Jacksonville 877
Moscow 780
Santa Clara 695
Hong Kong 551
Chandler 542
Singapore 447
Princeton 172
Ashburn 153
Roxbury 136
Beijing 126
Ann Arbor 96
Medford 91
Cambridge 89
Woodbridge 89
Rome 86
Boardman 84
Milan 82
The Dalles 77
Naples 75
Caserta 73
Seoul 71
Wilmington 69
Bremen 68
Hefei 54
Bengaluru 51
San Mateo 49
New York 47
Ho Chi Minh City 46
Nanjing 44
Dallas 42
São Paulo 40
Aversa 37
Munich 34
Des Moines 33
Seattle 32
Düsseldorf 27
Florence 21
Norwalk 20
Brussels 19
Hanoi 19
Jinan 18
Mountain View 18
Catania 17
Los Angeles 17
Marigliano 17
Padova 17
Houston 16
Napoli 16
Nuremberg 14
Bologna 13
Palermo 13
Radomsko 13
Shenyang 13
Torino 13
Fisciano 12
Rio de Janeiro 12
Bari 11
Perugia 11
Curitiba 10
Da Nang 10
Hangzhou 10
Helsinki 10
Porto Alegre 10
Tianjin 10
Atlanta 9
Auburn Hills 9
Brasília 9
Brooklyn 9
Nanchang 9
Salerno 9
Turin 9
Warsaw 9
Belo Horizonte 8
Como 8
Genova 8
Viterbo 8
Catanzaro 7
Genoa 7
Guangzhou 7
Kunming 7
Manaus 7
Parma 7
Taranto 7
Tokyo 7
Verona 7
Vienna 7
Asunción 6
Cagliari 6
Campinas 6
Cava de' Tirreni 6
Guarulhos 6
Istanbul 6
Pune 6
Recife 6
Somma 6
Tashkent 6
Zhengzhou 6
Baghdad 5
Bogotá 5
Totale 7.792
Salva come PNG Salva come JPEG
Nome #
SINDROME METABOLICA E TRATTAMENTO CON ANTIPSICOTICI: DIFFERENZE IN PAZIENTI CON DIAGNOSI DI SCHIZOFRENIA E DISTURBO BIPOLARE 556
Discrasie ematiche transitorie e persistenti indotte dalla clozapina durante le prime diciotto settimane di trattamento 422
CLOZAPINA E ALTRI ANTIPSICOTICI ATIPICI E TIPICI: INCIDENZA E DECORSO DELLE DISCRASIE EMATICHE DURANTE LE PRIME DICIOTTO SETTIMANE DI TRATTAMENTO 231
Trattamento combinato con clorimipramina ed aripiprazolo nella depressione resistente 180
TRATTAMENTO CON ANTIPSICOTICI E COMPARSA DI SINDROME METABOLICA: UNO STUDIO RETROSPETTIVO IN PAZIENTI SCHIZOFRENICI E BIPOLARI 155
Brain natriuretic peptide as a biomarker of asymptomatic clozapine-related heart dysfunction: a criterion for a more cautious administration. 136
Cancro della mammella e Alessitimia: Freno o Incentivo alla prevenzione? 131
Central and peripheral peptides regulating eating behaviour and energy homeostasis in anorexia nervosa and bulimia nervosa: a literature review 130
Magnetic resonance imaging of a transient splenial lesion of the corpus callosum resolved within a week 128
Campania Region (Italy) spontaneous reporting system and preventability assessment through a case-by-case approach: a pilot study on psychotropic drugs 128
Trattamento con antipsicotici e sindrome metabolica: uno studio retrospettivo in pazienti schizofrenici e bipolari 126
A systematic review on shared biological mechanisms of depression and anxiety in comorbidity with psoriasis, atopic dermatitis, and hidradenitis suppurativa 124
Sindrome metabolica e utilizzo di antipsicotici in pazienti con diagnosi di schizofrenia e disturbo bipolare 121
Transient and persistent blood dyscrasias induced by clozapine during the first 18 weeks of treatment 114
Bipolar Patients and Bullous Pemphigoid after Risperidone Long-Acting Injectable: A Case Report and a Review of the Literature 113
Antipsychotic treatment and metabolic syndrome: a retrospective study in schizophrenic and bipolar patients 111
Antipsychotic treatment and metabolic syndrome: a retrospective study in schizophrenic and bipolar patients 108
Clozapine versus other antipsychotics during the first 18 weeks of treatment: A retrospective study on risk factor increase of blood dyscrasias 108
Blood levels of mianserin and amitriptyline and clinical response in aged depressed patients 107
La depressione resistente al trattamento farmacologico: incremento dell’effetto antidepressivo della clorimipramina determinato dall’aripiprazolo 107
Aumento dei livelli plasmatici di colesterolo e trigliceridi nella bulimia nervosa 107
Antipsychotic Treatment and Metabolic Syndrome: a Comparison between Schizophrenic and Bipolar Patients. 107
Serotonin transporter polymorphism and potential response to SSRIs in bulimia nervosa 106
Duration of Untreated Illness in Patients with Obsessive-Compulsive Disorder and Its Impact on Long-Term Outcome: A Systematic Review 105
Vitamin D Deficiency and Risk Factors Related to Acute Psychiatric Relapses in Patients with Severe Mental Disorders: A Preliminary Study 105
L’Olanzapina è più rapida dell’Aloperidolo nell’indurre Sindrome Metabolica in pazienti schizofrenici ma non nei bipolari 105
Molecular Psychiatry: regulation of gene function 105
Plasma levels of interleukin-6 and tumor necrosis factor alpha in chronic schizophrenia: effects of clozapine treatment 104
From over- to under-weight: treatment of post-surgical anorexia nervosa in morbid obesity 103
Circulating ghrelin is decreased in non-obese and obese women with binge eating disorder as well as in obese non-binge eating women, but not in patients with bulimia nervosa 101
Risposta al trattamento con inibitori del reuptake della serotonina nel disturbo ossessivo-compulsivo ad esordio precoce 101
Brain-derived neurotrophic factor (BDNF) nello spettro del comportamento alimentare 101
Correlati neurofisiologici della risposta clinica ai neurolettici tipici in pazienti schizofrenici al primo episodio di malattia 98
Are antipsychotics useful in the treatment of anorexia nervosa? A review of the literature 98
Aripiprazole augmentation strategy in clomipramine-resistant depressive patients: An open preliminary study. 98
A Multivariate Analysis of Depression Prevalence in Psoriasis Patients: A Cohort Study 97
Investigation of peptide YY and ghrelin responses to a test meal in bulimia nervosa. 96
Discrasie ematiche transitorie e persistenti e trattamento con clozapina nelle prime diciotto settimane di terapia 96
In rats the reserpine induced increase of brain NGF biosynthesis is mediated by corticosteroids 95
Metabolic Syndrome and Antipsychotic treatment: how about schizophrenia and bipolar disorder? 95
Duration of untreated illness and outcome of obsessive-compulsive disorder: A naturalistic follow-up study. 95
Changes of cholinergic, noradrenergic and serotonergic synaptic transmission indices elicited by Ethylcholine Aziridinium ion (AF64A) infused intraventricularly 93
Delirium and Psychiatric Sequelae Associated to SARS-CoV-2 in Asymptomatic Patients With Psychiatric History and Mild Cognitive Impairment as Risk Factors: Three Case Reports 93
Il trattamento farmacologico dei sintomi negativi della schizofrenia 92
Altered ghrelin physiology in bulimia nervosa: integration with leptin changes 92
A hypothesis on Cotard’s syndrome as an evolution of obsessive-compulsive disorder 91
Leptin production in Bulimia Nervosa 90
Peripheral brain derived neurotrophic factor (BDNF) in patients with unipolar depression or with bipolar I and II disorders 90
Duration of untreated illness and outcome of the OCD: a three-year prospective study 90
Pemphigus and skin disease: A comparison of the incidence of stressful life events and personality disorders 89
Studio longitudianle dei livelli plasmatici del cortisolo e delle catecolamine e della risposta al test al desametazone in pazienti con disordine affettivo bipolare 89
Plasma concentrations of amino acids in chronic schizophrenics treated with clozapine 88
Clozapine treatment and other atypical and typical antipsychotics: incidence and course of blood dyscrasias during the first eighteen weeks of treatment 88
Transsynaptic regulation of nerve growth factor gene expression 88
Drug safety warnings in psychiatry: Adverse drug reactions' signaling from 2002 to 2014 88
Safety and Tolerability of Mood Stabilisers 88
Decreased blood levels of tumor necrosis factor-alpha in patients with obsessive-compulsive disorder 86
Second-Generation Antipsychotics' Effectiveness and Tolerability: A Review of Real-World Studies in Patients with Schizophrenia and Related Disorders 85
Add-on oral olanzapine worsens hallucinations in schizoaffective disorder. 85
Comorbidity of obsessive-compulsive disorder and schizotypal personality disorder: Clinical response and treatment resistance to pharmacotherapy in a 3-year follow-up naturalistic study 85
Opposite modifications in circulating leptin and solubile leptin receptor across the eating disorder spectrum 84
Long-term pharmacological treatment in schizophrenia 84
L'ansia , la depressione e il movimento nell'anziano 84
Response to lithium prophylaxis in schizoaffective psychoses 83
Effect of treatment duration on plasma levels of clozapine and n-desmethylclozapine in men and women 83
Social Cognition Individualized Activities Lab for Social Cognition Training and Narrative Enhancement in Patients With Schizophrenia: A Randomized Controlled Study to Assess Efficacy and Generalization to Real-Life Functioning (Prot. n°: NCT05130853) 83
I neurosteroidi ed il recettore periferico delle benzodiazepine 82
Clinical and neurophysiological findings in schizophrenic patients with enlarged and normal ventricles 82
Livelli plasmatici di TNF alfa in pazienti schizofrenici 82
Investigating the Relationship between White Matter Connectivity and Motivational Circuits in Subjects with Deficit Schizophrenia: A Diffusion Tensor Imaging (DTI) Study 82
Pronounced early increase in circulating leptin predicts a lower weight gain during clozapine treatment 81
Mismatch Negativity and P3a Impairment through Different Phases of Schizophrenia and Their Association with Real-Life Functioning 81
Steroid regulation of Nerve Growth Factor biosynthesis in the CNS 80
Regulation of Nerve Growth Factor receptor biosynthesis: in vitro and in vivo studies 80
Pharmacology of Nerve Growth Factor biosynthesis in rat brain 80
Olanzapine Is Faster than Haloperidol in Inducing Metabolic Abnormalities in Schizophrenic and Bipolar Patients 80
Circulating brain-derived neurotrophic factor is decreased in women with anorexia and bulimia nervosa but not in women with binge eating disorder: relationships to comorbid depression, psychopathology and hormonal variables 79
La sindrome metabolica e l’utilizzo di antipsicotici: quali differenze in schizofrenia e disturbo bipolare? 79
Livelli plasmatici degli aminoacidi nei pazienti affetti da schizofrenia cronica. 79
Sciatic nerves transplanted into the CNS exhibit elevated nerve growth factor (NGF) protein levels 79
Il monitoraggio plasmatico della clozapina e dei suoi principali metaboliti in pazienti schizofrenici 79
Regulation of nerve growth factor receptor mRNA content by dexamethasone: in vitro and in vivo studies 78
Transcriptional regulation of Nerve Growth Factor gene 78
Plasma leptin and soluble leptin receptor in patients with eating disorders 78
Effect of fluoxetine on the plasma concentrations of clozapine and its major metabolites in patients with schizophrenia 77
Long-term treatment with clozapine does not affect morning circulating levels of allopregnanolone and THDOC in patients with schizophrenia: a preliminary study 77
Plamsa leptin response to acute fasting and refeeding in untreated women with bulimia nervosa 77
Il monitoraggio plasmatico della clozapina e dei suoi principali metaboliti in pazienti schizofrenici 77
Induction of Nerve Growth Factor gene expression by Beta-adrenergic receptor activation 77
La regolazione della sintesi del Nerve Growth factor nel Sistema Nervoso Centrale: gli steroidi come potenziali mediatori 77
Neonatal mild stress influences the programming of some adult cerebral biochemical structures 77
Flattened cortisol awakening response in chronic patients with schizophrenia onset after cannabis exposure 76
DEPRESSION IN CHRONIC KIDNEY DISEASE 76
Una strategia di trattamento combinato con cloripramina ed aripiprazolo nella depressione resistente 76
Gli endocannabinoidi nei disturbi del comportamento alimentare: implicazioni fisiopatologiche 76
Preliminary observations on gabapentin strategy in clozapine-resistant patients: lack of pharmacokinetic interactions 75
Correlazione tra risposta clicnica e livelli plasmatici di clozapina e principali metaboliti in un trial standardizzato 75
L'anoressia mentale: aspetti eziopatogenetici clinici e terapeutici 75
Disturbo ossessivo-compulsivo ad esordio precoce: caratteristiche cliniche e risposta al trattamento 75
The role of drug therapies in the treatment of anorexia and bulimia nervosa: a review of the literature 74
Totale 10.301
Salva come PNG Salva come JPEG
Categoria #
all - tutte 56.579
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 56.579
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021775 0 0 0 0 0 23 176 153 18 197 146 62
2021/20221.198 70 7 21 38 435 20 25 44 53 61 90 334
2022/20232.183 187 59 48 160 259 182 4 124 1.042 17 54 47
2023/2024991 80 27 81 76 287 58 35 60 14 26 84 163
2024/20252.766 22 36 49 76 428 394 230 203 413 555 206 154
2025/20264.268 328 315 387 440 812 1.986 0 0 0 0 0 0
Totale 15.482